Bionaut Labs
Bionauts: Precision medicine via remote-controlled micro-robots for safe, precise CNS disorder treatment.
Founded
2016Bionauts: Precision medicine via remote-controlled micro-robots for safe, precise CNS disorder treatment.
Bionaut Labs, founded with a mission to revolutionize the treatment of central nervous system (CNS) disorders, leverages precision medicine through remote-controlled micro-robots known as Bionauts. These micro-robots are designed to navigate complex 3D trajectories within the human body, providing local treatment and diagnostic detection in deep anatomical locations. The company's vision is to offer safer and more effective treatments for CNS disorders by achieving accurate and direct access to intricate brain structures.
Notable figures associated with Bionaut Labs include leading experts in the fields of robotics, neuroscience, and precision medicine. The company has attracted significant investment from prominent venture capital firms focused on healthcare innovation. Key achievements include successful preclinical trials demonstrating the efficacy and safety of Bionauts in navigating and treating deep brain structures. Bionaut Labs' pioneering approach has the potential to significantly impact the field of neurology by offering new therapeutic options for previously intractable CNS conditions.
Companies similar to Bionaut Labs include NeuroBionics, Biomotum, Escape Bio and CuraSen Therapeutics.
Bionaut Labs was founded in 2016.
Bionaut Labs' headquarters is located in Los Angeles, CA, US.
Bionaut Labs' most recent funding round was for $43.2M (USD) in November 2022.
As of Nov 28, 2022, Bionaut Labs has disclosed funding of $63.2M (USD). Undisclosed round amounts are excluded.
Bionaut Labs has 61 employees as of Feb 4, 2024.
CuraSen Therapeutics
curasen.com
